Mativ vs Materion
MATV and MTRN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MATV and MTRN compare
Materion is the larger company, worth 6.4 times as much as Mativ ($4.1B against $641M).
On earnings, Mativ is cheaper: it trades at 7.2× trailing earnings, against 46.1× for Materion.
Materion grew revenue faster over the last twelve months (21.6% versus 1.1% for Mativ).
Mativ keeps more of each dollar of sales as profit, with a net margin of 4.5% compared with 4.3% at Materion.
Both pay dividends: Mativ yields 3.4% and Materion 0.22%.
Mativ scores higher on the StockData Score (15 against 12 for Materion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MATV | MTRN |
|---|---|---|
| Size and price | ||
| Market cap | $641M | $4.1B |
| Share price | $11.61 | $197.80 |
| Change, 1 year | −12.0% | 68.6% |
| Change, 5 years | −63.0% | 126% |
| Beta (5Y) | 1.95 | 2.54 |
| Employees | 5,000 | 2,880 |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 6 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 | 3 |
| Health score | 1 | 3 (better) |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 7.2× (better) | 46.1× |
| P/S | 0.3× (better) | 2.0× |
| P/B | 1.4× (better) | 4.1× |
| EV/EBITDA | 7.5× (better) | 23.0× |
| P/FCF | 5.0× | – |
| FCF yield | 19.9% | – |
| Fair value | $22.76 | $114.35 |
| Margin of safety | 49.0% (better) | −73.0% |
| Growth | ||
| Revenue growth (TTM) | 1.1% | 21.6% (better) |
| Revenue growth, 5Y average | 13.1% (better) | 8.7% |
| Net income growth (TTM) | – | 454% |
| EPS growth (TTM) | – | 443% |
| EPS growth, 5Y average | – | 36.7% |
| Profitability | ||
| Gross margin | 19.4% (better) | 16.0% |
| Operating margin | 3.5% | 6.0% (better) |
| Net margin | 4.5% (better) | 4.3% |
| FCF margin | 6.4% | – |
| Return on equity | 20.2% (better) | 9.5% |
| Return on invested capital | 3.9% | 8.4% (better) |
| Financial health | ||
| Debt / equity | 2.07 | 0.46 (better) |
| Net debt / EBITDA | 4.37 | 2.21 (better) |
| Interest coverage | 1.0× | 4.1× (better) |
| Current ratio | 1.98 | 2.94 (better) |
| Altman Z-score | 1.41 | 5.26 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.4% (better) | 0.22% |
| Payout ratio | 25.0% | 13.0% |
| Years of dividend growth | 0 | 14 (better) |
| Dividend growth, 5Y average | −25.6% | 4.1% (better) |
| Shareholder yield | 3.4% (better) | 0.22% |
| Ownership | ||
| Held by institutions | 93.9% | 98.0% |
| Held by insiders | 2.3% | 1.7% |
| Insider net buying, 12 months | – | −$18.5M |
| Short interest, % of float | 1.6% | 2.5% |
Go deeper
- MATV stock overview
- MATV income statement
- MATV valuation and score
- MTRN stock overview
- MTRN income statement
- MTRN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.